# Treasure Global Inc: financial statements, quarterly TGL · Nasdaq · CIK 1905956 · [Industrials](/sectors/industrials.md) · fiscal year ends Jun 30 Pages: [Overview](/companies/tgl.md) · [Financials](/companies/tgl/financials.md) · [Filings](/companies/tgl/filings.md) · [Insiders](/companies/tgl/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tgl/financials.md?period=annual). ## Income statement | Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [13.5](/filings/0001213900-23-086880.md) | [6.7](/filings/0001213900-24-014024.md) | [1.6](/filings/0001213900-24-042904.md) | [0.3 d](/filings/0001213900-25-099542.md) | [0.2](/filings/0001213900-25-110807.md) | [0.3](/filings/0001213900-26-019296.md) | [0.7](/filings/0001213900-26-059507.md) | [1.2 d](/filings/0001213900-26-109073.md) | [0.2](/filings/0001213900-25-110807.md) | [1.1](/filings/0001213900-26-019296.md) | [1.5](/filings/0001213900-26-059507.md) | [2.4 d](/filings/0001213900-26-109073.md) | | Cost of revenue | $m | [13.3](/filings/0001213900-24-098275.md) | [6.4](/filings/0001213900-25-014264.md) | [1.4](/filings/0001213900-25-044149.md) | [0.2 d](/filings/0001213900-25-099542.md) | [0.0](/filings/0001213900-25-110807.md) | [0.1](/filings/0001213900-26-019296.md) | [0.2](/filings/0001213900-26-059507.md) | [0.4 d](/filings/0001213900-26-109073.md) | [0.2](/filings/0001213900-25-110807.md) | [1.1](/filings/0001213900-26-019296.md) | [1.5](/filings/0001213900-26-059507.md) | [2.4 d](/filings/0001213900-26-109073.md) | | Gross profit | $m | [0.2](/filings/0001213900-24-098275.md) | [0.3](/filings/0001213900-25-014264.md) | [0.2](/filings/0001213900-25-044149.md) | [0.1 d](/filings/0001213900-25-099542.md) | [0.2](/filings/0001213900-25-110807.md) | [0.2](/filings/0001213900-26-019296.md) | [0.5](/filings/0001213900-26-059507.md) | [0.8 d](/filings/0001213900-26-109073.md) | [0.0](/filings/0001213900-25-110807.md) | [0.0](/filings/0001213900-26-019296.md) | [0.0](/filings/0001213900-26-059507.md) | [0.0 d](/filings/0001213900-26-109073.md) | | Research and development | $m | [0.1](/filings/0001213900-24-098275.md) | [0.1](/filings/0001213900-25-014264.md) | [0.2](/filings/0001213900-25-044149.md) | [(0.4) d](/filings/0001213900-25-110807.md) | [0.0](/filings/0001213900-25-110807.md) | [0.0](/filings/0001213900-26-019296.md) | [0.0](/filings/0001213900-26-059507.md) | [0.1 d](/filings/0001213900-26-109073.md) | [0.8](/filings/0001213900-25-110807.md) | [0.0](/filings/0001213900-26-019296.md) | [0.1](/filings/0001213900-26-059507.md) | [0.8 d](/filings/0001213900-26-109073.md) | | Operating income | $m | [(1.9)](/filings/0001213900-24-098275.md) | [(1.1)](/filings/0001213900-25-014264.md) | [(1.4)](/filings/0001213900-25-044149.md) | [(1.7) d](/filings/0001213900-25-099542.md) | [(0.8)](/filings/0001213900-25-110807.md) | [(0.7)](/filings/0001213900-26-019296.md) | [(0.0)](/filings/0001213900-26-059507.md) | [(20.5) d](/filings/0001213900-26-109073.md) | [(1.7)](/filings/0001213900-25-110807.md) | [(7.7)](/filings/0001213900-26-019296.md) | [(4.2)](/filings/0001213900-26-059507.md) | [(2.8) d](/filings/0001213900-26-109073.md) | | Interest expense | $m | [0.0](/filings/0001213900-23-086880.md) | [0.0](/filings/0001213900-24-014024.md) | [0.0](/filings/0001213900-25-044149.md) | [0.0 d](/filings/0001213900-25-099542.md) | [0.0](/filings/0001213900-25-110807.md) | [0.0](/filings/0001213900-26-019296.md) | [0.0](/filings/0001213900-26-059507.md) | [0.0 d](/filings/0001213900-26-109073.md) | [0.0](/filings/0001213900-25-110807.md) | [0.0](/filings/0001213900-26-019296.md) | [0.0](/filings/0001213900-26-059507.md) | [(0.0) d](/filings/0001213900-26-109073.md) | | Income tax | $m | [0.0](/filings/0001213900-24-098275.md) | [0.0](/filings/0001213900-25-014264.md) | [(0.0) d](/filings/0001213900-25-044149.md) | [0.0 d](/filings/0001213900-25-099542.md) | [0.0](/filings/0001213900-25-110807.md) | [0.0](/filings/0001213900-26-019296.md) | [0.0 d](/filings/0001213900-26-059507.md) | [0.3 d](/filings/0001213900-26-109073.md) | not reported | [0.1](/filings/0001213900-26-019296.md) | [0.1](/filings/0001213900-26-059507.md) | [0.1 d](/filings/0001213900-26-109073.md) | | Net income | $m | [(2.1)](/filings/0001213900-25-044149.md) | [(1.2)](/filings/0001213900-25-044149.md) | [(1.7)](/filings/0001213900-25-044149.md) | [(1.5) d](/filings/0001213900-25-099542.md) | [(1.0)](/filings/0001213900-26-059507.md) | [(0.2)](/filings/0001213900-26-059507.md) | [1.3](/filings/0001213900-26-059507.md) | [(23.5) d](/filings/0001213900-26-109073.md) | [(2.1)](/filings/0001213900-26-059507.md) | [(3.1)](/filings/0001213900-26-059507.md) | [(2.3)](/filings/0001213900-26-059507.md) | [(3.5) d](/filings/0001213900-26-109073.md) | | Diluted EPS | $ per share | [(7.83)](/filings/0001213900-24-098275.md) | [(2.22)](/filings/0001213900-25-014264.md) | [(116.03)](/filings/0001213900-25-044149.md) | not reported | [(17.62)](/filings/0001213900-25-110807.md) | [(11.32)](/filings/0001213900-26-019296.md) | [21.79](/filings/0001213900-26-059507.md) | not reported | [(0.38)](/filings/0001213900-25-110807.md) | [(3.47)](/filings/0001213900-26-019296.md) | [(1.39)](/filings/0001213900-26-059507.md) | not reported | | Basic EPS | $ per share | [(7.83)](/filings/0001213900-24-098275.md) | [(2.22)](/filings/0001213900-25-014264.md) | [(116.03)](/filings/0001213900-25-044149.md) | not reported | [(17.62)](/filings/0001213900-25-110807.md) | [(11.32)](/filings/0001213900-26-019296.md) | [21.79](/filings/0001213900-26-059507.md) | not reported | [(0.38)](/filings/0001213900-25-110807.md) | [(3.47)](/filings/0001213900-26-019296.md) | [(1.39)](/filings/0001213900-26-059507.md) | not reported | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues - Cost of revenue: us-gaap:CostOfRevenue - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | period not labelled (2025-02-28) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | period not labelled (2025-11-10) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [4.2](/filings/0001213900-24-042904.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.1](/filings/0001213900-26-109073.md) | not reported | not reported | not reported | | Current assets | $m | [1.2](/filings/0001213900-24-042904.md) | [1.0](/filings/0001213900-25-099542.md) | [1.2](/filings/0001213900-24-098275.md) | [2.1](/filings/0001213900-25-014264.md) | not reported | [10.7](/filings/0001213900-25-044149.md) | [5.5](/filings/0001213900-26-109073.md) | [4.3](/filings/0001213900-25-110807.md) | not reported | [17.0](/filings/0001213900-26-019296.md) | [17.2](/filings/0001213900-26-059507.md) | [9.7](/filings/0001213900-26-109073.md) | | Total assets | $m | [4.2](/filings/0001213900-24-042904.md) | [4.3](/filings/0001213900-25-099542.md) | [7.1](/filings/0001213900-24-098275.md) | [19.1](/filings/0001213900-25-014264.md) | not reported | [30.4](/filings/0001213900-25-044149.md) | [14.9](/filings/0001213900-26-109073.md) | [16.6](/filings/0001213900-25-110807.md) | not reported | [24.2](/filings/0001213900-26-019296.md) | [21.6](/filings/0001213900-26-059507.md) | [19.3](/filings/0001213900-26-109073.md) | | Current liabilities | $m | [1.1](/filings/0001213900-24-042904.md) | [0.9](/filings/0001213900-25-099542.md) | [0.8](/filings/0001213900-24-098275.md) | [0.7](/filings/0001213900-25-014264.md) | not reported | [1.3](/filings/0001213900-25-044149.md) | [3.7](/filings/0001213900-26-109073.md) | [3.5](/filings/0001213900-25-110807.md) | not reported | [3.9](/filings/0001213900-26-019296.md) | [4.8](/filings/0001213900-26-059507.md) | [4.5](/filings/0001213900-26-109073.md) | | Total liabilities | $m | [1.1](/filings/0001213900-24-042904.md) | [0.9](/filings/0001213900-25-099542.md) | [0.8](/filings/0001213900-24-098275.md) | [0.7](/filings/0001213900-25-014264.md) | not reported | [1.3](/filings/0001213900-25-044149.md) | [4.1](/filings/0001213900-26-109073.md) | [4.6](/filings/0001213900-25-110807.md) | not reported | [6.3](/filings/0001213900-26-019296.md) | [6.0](/filings/0001213900-26-059507.md) | [5.8](/filings/0001213900-26-109073.md) | | Short-term borrowings | $m | not reported | not reported | not reported | not reported | [0.1](/filings/0001213900-26-059507.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [3.1](/filings/0001213900-25-044149.md) | [3.4](/filings/0001213900-26-059507.md) | [6.3](/filings/0001213900-26-059507.md) | [18.4](/filings/0001213900-26-059507.md) | not reported | [29.1](/filings/0001213900-26-059507.md) | [10.7](/filings/0001213900-26-109073.md) | [12.0](/filings/0001213900-26-059507.md) | not reported | [18.0](/filings/0001213900-26-059507.md) | [15.6](/filings/0001213900-26-059507.md) | [13.6](/filings/0001213900-26-109073.md) | - Cash and equivalents: us-gaap:Cash - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Short-term borrowings: us-gaap:ShortTermBorrowings - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $k | [(1,895)](/filings/0001213900-24-098275.md) | [(1,195) d](/filings/0001213900-25-014264.md) | [(1,071) d](/filings/0001213900-25-044149.md) | [(552) d](/filings/0001213900-25-099542.md) | [(976)](/filings/0001213900-25-110807.md) | [(606) d](/filings/0001213900-26-019296.md) | [(4,235) d](/filings/0001213900-26-059507.md) | [(3,664) d](/filings/0001213900-26-109073.md) | [(1,761)](/filings/0001213900-25-110807.md) | [(2,970) d](/filings/0001213900-26-019296.md) | [(460) d](/filings/0001213900-26-059507.md) | [(1,693) d](/filings/0001213900-26-109073.md) | | Capital expenditure | $k | [6.2](/filings/0001213900-24-098275.md) | [8.2 d](/filings/0001213900-25-014264.md) | [0.6 d](/filings/0001213900-25-044149.md) | [1.7 d](/filings/0001213900-25-099542.md) | not reported | not reported | [1.8 d](/filings/0001213900-26-059507.md) | [10.3 d](/filings/0001213900-26-109073.md) | [645](/filings/0001213900-25-110807.md) | [333 d](/filings/0001213900-26-019296.md) | [67.3 d](/filings/0001213900-26-059507.md) | [7.7 d](/filings/0001213900-26-109073.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment ## Shares | Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [13.9](/filings/0001213900-23-086880.md) | [17.3](/filings/0001213900-24-014024.md) | [0.2](/filings/0001213900-24-042904.md) | [0.3](/filings/0001213900-24-098275.md) | [0.5](/filings/0001213900-25-014264.md) | [0.0](/filings/0001213900-25-044149.md) | [0.1](/filings/0001213900-25-110807.md) | [0.0](/filings/0001213900-26-019296.md) | [0.1](/filings/0001213900-26-059507.md) | [5.7](/filings/0001213900-25-110807.md) | [0.9](/filings/0001213900-26-019296.md) | [1.7](/filings/0001213900-26-059507.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 5,159,897 at 2026-10-13, from the cover of the [10-K filed 2026-10-13](/filings/0001213900-26-109073.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.